Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations

Written by Ruchika Sharma Published On 2022-08-25T17:00:43+05:30 | Updated On 25 Aug 2022 5:09 PM IST

Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations

New Delhi: Through a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed the retail prices of 45 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 100th Authority meeting dated 05.08.2022.

The said formulations include diabetes medications such as Pure & Cure Healthcare and Cadila Pharma's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Torrent Pharma's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Exemed Pharma and Cipla's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Bajaj Healthcare and J.B. Chemicals & Pharmaceuticals's Sitagliptin Phosphate and Metformin Hydrochloride Tablets, MSN Labs and Eris Lifesciences's Linagliptin and Metformin Hydrochloride extended-release Tablet.

The fixed price list table further includes Aagya Biotech and German Remedies Pharma's Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets, Micro Labs's Amoxycillin and Potassium Clavulanate Oral Suspension IP., Sirmour Remedies and Mankind Pharma Ltd.'s Diclofenac, Methyl Salicylate & Menthol Gel, Pure and Cure Healthcare and Cadila Pharma's Omeprazole (GR) & Domperidone (SR) Capsules, Acme Generics and Mankind Prime Labs's Gastro-Resistant Esomeprazole and Domperidone Sustained Release Capsule, Pure and Cure Healthcare and Torrent Pharma's Etamsylate & Tranexamic Acid Tablets.

This comes after in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30^th May, 2013 and S. O. 701(E) dated 10^th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1.	Cyclosporine Eye Drop	Each ml contains: Cyclosporine IP 0.5mg	1 ml	M/s Indiana Opthalmics / M/s Intas Pharmaceuticals Ltd.	96.15
2.	Omeprazole (GR) & Domperidone (SR) Capsules	Each Hard Gelatin Capsule Contains: Omeprazole IP 20mg (As Gastro Resistant Pellets) Domperidone IP 30mg (As Sustained Release Pellets)	1 Capsule	M/s Pure and Cure Healthcare Pvt. Ltd./M/s Cadila Pharmaceuticals Ltd.	9.53
3.	Pantoprazole Dual Release Gastro Resistant Tablets	Each dual-release gastro resistant tablet contains: Pantoprazole Sodium IP eq. to Pantoprazole 80mg	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Hetero Healthcare Ltd.	11.16
4.	Gastro-Resistant Esomeprazole and Domperidone Sustained Release Capsule	Each hard gelatin Capsule Contains: Esomeprazole Magnesium Trihydrate eq. to Esomeprazole IP 40mg (As Gastro-resistant pellets) Domperidone IP 30mg (As sustained release pellets)	1 Capsule	M/s Acme Generics Private Limited / M/s Mankind Prime Labs Pvt. Ltd.	11.32
5.	Amlodipine and Atenolol tablets	Each uncoated tablet contains: Amlodipine Besilate IP eq. to Amlodipine 5mg Atenolol IP 50mg	1 Tablet	M/s East African (India) Overseas / M/s Softdeal Pharmaceuticals Pvt. Ltd.	5.21
6.	Etamsylate & Tranexamic Acid Tablets	Each film coated tablet contains: Etamsylate BP 250mg, Tranexamic Acid IP 250mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd.	17.82
7.	Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets	Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5mg Caffeine (Anhydrous) IP 30mg Diphenhydramine Hydrochloride IP 25mg	1 Tablet	M/s Aagya Biotech Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	3.73
8.	Amoxycillin and Potassium Clavulanate Oral Suspension IP	Each Composite Pack Contains: A & B Each 5ml of reconstituted suspension contains: A. Amoxycillin Trihydrate IP eq. to Amoxycillin 600mg, Potassium Calvulanate IP (as Potassium Clavulanate Diluted IP) eq. to Clavulanic Acid 42.9mg 2x30ml Sterile water for reconstitution of Dry syrup Each ampoule containing 30ml sterile water for reconstitution of Dry Syrup (as sterile water for Injection IP)	Per Combi Pack	M/s Micro Labs Limited	168.43
9.	Diclofenac, Methyl Salicylate & Menthol Gel	Composition: Diclofenac Diethylamine IP 2.32%w/w (eq. to Diclofenac Sodium 2.00% w/w) Methyl Salicylate IP 10.00%w/w Menthol IP 5.00%w/w	1 gm	M/s Sirmour Remedies Pvt. Ltd. / M/s Mankind Pharma Ltd.	3.93
10.	Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an sustained release form) IP 500mg	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd.	18.67
11.	Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as sustained release form) IP 1000mg	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd.	20.06
12.	Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as sustained release form) IP 1000mg	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd.	21.56
13.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an Extended release form) IP 500mg	1 Tablet	M/s Torrent Pharmaceuticals Ltd.	18.00
14.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an Extended release form) IP 1000mg	1 Tablet	M/s Torrent Pharmaceuticals Ltd.	20.00
15.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as Extended release form) IP 1000mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd.	20.06
16.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as Extended release form) IP 500mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd.	18.67
17.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an Extended release form) IP 500mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd.	20.00
18.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an Extended release form) IP 1000mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd.	21.00
19.	Sitagliptin and Metformin Hydrochloride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Sai Primus Life Biotech Private Limited / M/s Primus Remedies Pvt. Ltd.	18.34
20.	Sitagliptin and Metformin Hydrochloride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 850mg	1 Tablet	M/s Sai Primus Life Biotech Private Limited / M/s Primus Remedies Pvt. Ltd.	19.26
21.	Sitagliptin and Metformin Hydrochloride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Sai Primus Life Biotech Private Limited / M/s Primus Remedies Pvt. Ltd.	20.02
22.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an Extended release form) IP 1000mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd.	20.00
23.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an Extended release form) IP 500mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd.	18.00
24.	Sitagliptin and Metformin Hydrochloride (Sustained Release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP 500 mg (as Sustained Release form)	1 Tablet	M/s Mascot Health Series Private Limited / M/s Alembic Pharmaceuticals Ltd.	16.07
25.	Sitagliptin and Metformin Hydrochloride (Sustained Release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP 1000 mg (as Sustained Release form)	1 Tablet	M/s Mascot Health Series Private Limited / M/s Alembic Pharmaceuticals Ltd.	17.85
26.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP (as Extended Release form) 1000 mg	1 Tablet	M/s Intas Pharmaceuticals Ltd.	21.56
27.	Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Metformin Hydrochloride IP (as Extended Release form) 500 mg	1 Tablet	M/s Intas Pharmaceuticals Ltd.	18.67
28.	Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Metformin Hydrochloride IP (as extended Release form) 1000 mg	1 Tablet	M/s Intas Pharmaceuticals Ltd.	20.06
29.	Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP (as extended Release form) 500 mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.	20.17
30.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an extended release form) IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Cipla Ltd.	18.67
31.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride (as an extended release form) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Cipla Ltd.	20.06
32.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an extended release form) IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Cipla Ltd.	20.00
33.	Sitagliptin and Metformin Hydrochloride (Extended release) Tablets Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (as an extended release form) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Cipla Ltd.	21.56
34.	Sitagliptin Phosphate and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Bajaj Healthcare Ltd. / M/s J.B. Chemicals & Pharmaceuticals Ltd.	18.34
35.	Sitagliptin Phosphate and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Bajaj Healthcare Ltd. / M/s J.B. Chemicals & Pharmaceuticals Ltd.	20.02
36.	Purified Freeze- Dried Human Coagulation Factor VIII, Virus Inactivated IP (Immunate)	Composition: Purified Freeze-Dried Human Coagulation Factor VIII, Virus Inactivated IP 1000IU 1 vial with 10ml Sterilized Water for Injection	Per Pack	M/s Baxalta Bioscience India Pvt. Ltd.	11606.67
37.	Linagliptin and Metformin Hydrochloride extended-release Tablet	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP (as extended release) 1000mg	1 Tablet	M/s MSN Laboratories Pvt. Ltd. / M/s Eris Lifesciences Limited	16.37
38.	Linagliptin and Metformin Hydrochloride extended-release Tablet	Each film coated tablet contains: Linagliptin 5mg Metformin Hydrochloride IP (as extended release) 1000mg	1 Tablet	M/s MSN Laboratories Pvt. Ltd. / M/s Eris Lifesciences Limited	25.33
39.	Acetazolamide Extended-Release Capsules	Each capsule contains: Acetazolamide IP 500mg	1 Capsule	M/s Sidmak Laboratories (India) Pvt. Ltd. / M/s Sun Pharma Laboratories Limited	8.15
40.	Beclomethasone Dipropionate, Clotrimazole & Neomycin Sulphate Cream	Composition: Beclomethasone Dipropionate IP 0.025%w/w, Clotrimazole IP 1.00%w/w, Neomycin Sulphate IP 0.50% w/w	1 Gram	M/s Pharma Force Lab / M/s Torrent Pharmaceuticals Ltd.	6.33
41.	Pantoprazole Dual Release Gastro Resistant Tablets	Each Dual Release Gastro Resistant Tablet Contains: Pantoprazole Sodium Eq. to Pantoprazole 80mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Limited	15.49
42.	Benidipine & Telmisartan Tablets	Each film coated tablet contains: Benidipine Hydrochloride JP 4mg Telmisartan IP 40mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd.	12.70
43.	Benidipine & Telmisartan Tablets	Each film coated tablet contains: Benidipine Hydrochloride JP 4mg Telmisartan IP 80mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd.	9.94
44.	Cilnidipine, Telmisartan & Chlorthalidone Tablets	Each Film Coated Tablet contains: Cilnidipine 10mg Telmisartan 40mg Chlorthalidone 6.25 mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.	12.50
45.	Budesonide & Formoterol Fumarate Respirator Suspension	Each 2ml contains: Budesonide IP 0.5mg Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 20mcg	1 ml	M/s Axa Parenterals Limited / M/s Mankind Pharma Ltd.	22.75

Notice further reads:

(a) The manufacturer of the above-mentioned formulations i.e., "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from the date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above-mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of the retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded

For more details, check out the official notice on the official site of NPPA:

https://medicaldialogues.in/pdf_upload/nppa-184257.pdf

NPPANational Pharmaceutical Pricing Authorityprice fixationLinagliptinmetforminmankind pharmaparacetamolSitagliptincadila pharmaMSN labseris lifesciencestorrent pharmaciplaJB chemicals

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751